Polls show Democratic voters are focused on reforming healthcare — but opinions vary widely on what, exactly, they would like to see changed.

The Trump administration wants to increase transparency in prescription drug pricing. But health economists say the administration's call to tie prices to what other nations pay might work better.

Once a tiny specialty that drew mostly psychiatrists, addiction medicine is expanding its accredited training to include primary care residents and "social justice warriors" who see it as a calling.

A tiny fraction of American women choose home birth, but that number is inching up. And in some social circles it's downright trendy. One pregnant mom-to-be investigates the pros and cons.

The Indianapolis-based drugmaker said Monday that it would offer a generic version of Humalog insulin, one of its best-selling medicines. The move could help blunt criticism about high prices.

It was Oregon's first pediatric case in more than 30 years. "It was difficult to take care of him, to watch him suffer," says Judith Guzman-Cottrill, an infectious-disease specialist.

Critics question claims by federal officials that CanaRX jeopardizes patient safety. Many U.S. companies, cities, counties and school districts rely on the firm to help employees get cheaper medicine.

Legislation introduced in Texas this week would force the state's health care providers and health insurers to mediate payment disputes before they send bills to patients.

A new poll by the Kaiser Family Foundation shows that many people struggle to pay for medicines and that a majority of Americans would welcome a range of government interventions to lower prices.

In 1991, the Supreme Court upheld restrictions on family planning providers that are similar to rules proposed by the Trump Administration. But Trump critics say the legal landscape has changed.